Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1698.00 | 1791.00 | 0.9481 | 0.9355 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 3.00 | 1791.00 | 0.0017 | -0.9607 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 1.00 | 4315.25 | 0.0002 | -0.9847 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4053.00 | 4315.25 | 0.9392 | 0.9283 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4308.00 | 4315.25 | 0.9983 | 0.9980 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 1363.00 | 4315.25 | 0.3159 | 0.0221 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4222.00 | 4315.25 | 0.9784 | 0.9747 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4560.00 | 4315.25 | 1.0567 | 1.0653 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4206.00 | 4315.25 | 0.9747 | 0.9704 |
| BT-20 | Linsitinib | 1 | uM | 7 | 2500.00 | 1312.79 | 4119.00 | 4315.25 | 0.9545 | 0.9465 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4330.00 | 4315.25 | 1.0034 | 1.0040 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4458.00 | 4315.25 | 1.0331 | 1.0383 | |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4644.00 | 4315.25 | 1.0762 | 1.0874 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4575.00 | 4315.25 | 1.0602 | 1.0693 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4155.00 | 4315.25 | 0.9629 | 0.9564 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4600.00 | 4315.25 | 1.0660 | 1.0758 |
| BT-20 | 17-AAG | 10 | uM | 7 | 2500.00 | 1312.79 | 1237.00 | 4315.25 | 0.2867 | -0.0340 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4556.00 | 4315.25 | 1.0558 | 1.0643 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 1388.00 | 4315.25 | 0.3217 | 0.0330 |
| BT-20 | Linsitinib | 10 | uM | 7 | 2500.00 | 1312.79 | 3430.00 | 4315.25 | 0.7949 | 0.7497 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4049.00 | 4315.25 | 0.9383 | 0.9272 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4073.00 | 4315.25 | 0.9439 | 0.9338 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3480.00 | 4315.25 | 0.8064 | 0.7645 |
| BT-20 | Erlotinib | 1 | uM | 7 | 2500.00 | 1312.79 | 3764.00 | 4315.25 | 0.8723 | 0.8470 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4171.00 | 4315.25 | 0.9666 | 0.9608 |